UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056478
Receipt number R000064509
Scientific Title Exploratory research on the functionality of test food for health
Date of disclosure of the study information 2024/12/22
Last modified on 2025/12/17 09:14:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory research on the functionality of test food for health

Acronym

Exploratory research on the functionality of test food for health

Scientific Title

Exploratory research on the functionality of test food for health

Scientific Title:Acronym

Exploratory research on the functionality of test food for health

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Proteomic analysis of the stratum corneum will be utilized to elucidate the biological response at the molecular level to sustained consumption of the test food.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Stratum corneum proteome

Key secondary outcomes

Skin properties (stratum corneum water content, sebum content, transepidermal water loss, melanin index, erythema index, skin color, spots, brown spots, red spots, redness, pores, porphyrins, texture, latent spots, wrinkles)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Food

Interventions/Control_1

After 28 days of pre-observation, the test food will be consumed once daily for 56-61 days continuously.

Interventions/Control_2

After 28 days of pre-observation, no test food will be consumed for 56-61 days.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

59 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy adults

Key exclusion criteria

1. Individuals with current or previous diagnoses of psychiatric disorders, chronic fatigue syndrome, or sleep disorders.
2. Individuals with current or previous diagnoses of diabetes, hepatic, renal, cardiac, or respiratory disorders, conditions affecting adrenal cortical hormone secretion, or other metabolic diseases.
3. Individuals with cutaneous scarring, inflammation, or other dermatological conditions (e.g., atopic dermatitis, acne) at the measurement site.
4. Individuals seeking dermatological consultation due to cutaneous conditions or discomfort at the measurement site.
5. Individuals undergoing dermatological pharmacotherapy at the measurement site.
6. Individuals who have undergone dermatological cosmetic procedures at the measurement site within four weeks prior to the commencement of the study or those who intend to undergo such procedures during the study period.
7. Individuals who have a habit of washing their face and body with strong irritation to the measurement site, such as using nylon towels.
8. Individuals who may use medications for allergic manifestations of the skin (e.g., erythema, pruritus) due to hay fever or similar conditions during the study period.
9. Individuals with allergies to the test food.
10. Pregnant or possibly pregnant.
11. Lactating mothers.
12. Individuals deemed unsuitable for participation in this study.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Atsushi
Middle name
Last name Gomi

Organization

Yakult Honsha Co., Ltd.

Division name

Yakult Central Institute

Zip code

186-8650

Address

5-11 Izumi, Kunitachi, Tokyo, Japan

TEL

042-577-8960

Email

atsushi-gomi@yakult.co.jp


Public contact

Name of contact person

1st name Koh
Middle name
Last name Maki

Organization

Yakult Honsha Co., Ltd.

Division name

Yakult Central Institute

Zip code

186-8650

Address

5-11 Izumi, Kunitachi, Tokyo, Japan

TEL

042-577-8960

Homepage URL


Email

ko-maki@yakult.co.jp


Sponsor or person

Institute

Yakult Honsha Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Yakult Honsha Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Station Clinic Research Ethics Committee

Address

3-12-8, Takaban, Meguroku, Tokyo, Japan

Tel

03-6452-2712

Email

nakajima.megumi888@eps.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 12 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

29

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 11 Month 18 Day

Date of IRB

2024 Year 12 Month 12 Day

Anticipated trial start date

2024 Year 12 Month 23 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 12 Month 17 Day

Last modified on

2025 Year 12 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064509